Clinical Thyroidology for the Public summarizes selected research studies discussed in the previous month’s issue of Clinical Thyroidology, an official publication of the American Thyroid Association. Editor-in-chief, Alan Farwell, MD, FACE
Volume 9 Issue 7
Available in pdf format for saving and printing and Web page format for viewing online
PDF Format for Saving and Printing
Clinical Thyroidology for the Public Volume 9 Issue 7 (PDF file, 3.4 MB)
TABLE OF CONTENTS – Web Format
THYROID CANCER Should the noninvasive encapsulated follicular variant of papillary thyroid cancer be re-classified as benign?
Nikiforov YE et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol. April 14, 2016 [Epub ahead of print].
(PDF File for saving and printing, 286 KB)
THYROID NODULES Reclassification of noninvasive follicular variant of papillary thyroid carcinoma as a benign condition will reduce the incidence of cancer in indeterminate thyroid biopsies
Faquin WC et al. Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in the Bethesda System for Reporting Thyroid Cytopathology. Cancer Cytopathol 2016;124:181-7. Epub October 12, 2015.
(PDF File for saving and printing, 118 KB)
THYROID NODULES Ultrasound and molecular marker analysis for diagnosing cancer in indeterminate thyroid nodules
De Napoli L et al. Indeterminate single thyroid nodule: synergistic impact of mutational markers and sonographic features in triaging patients to appropriate surgery. Thyroid 2016;26:390-4. Epub December 9, 2015.
(PDF File for saving and printing, 167 KB)
HYPERTHYROIDISM Risk factors for developing eye disease in patients with Graves’ hyperthyroidism
Khong JJ et al. Risk factors for Graves’ Orbitopathy; the Australian Thyroid-associated Orbitopathy Research (ATOR) Study. J Clin Endocrinol Metab. April 7, 2016 [Epub ahead of print].
(PDF File for saving and printing, 286 KB)
HYPOTHYROIDISM Thyroid-associated eye disease occurs in 6% of patients with Hashimoto’s Thyroiditis
Kahaly GJ et al Thyroid stimulating antibodies are highly prevalent in Hashimoto’s thyroiditis and associated orbitopathy. J Clin Endocrinol Metab. March 10, 2016 [Epub ahead of print].
(PDF File for saving and printing, 125 KB)
HYPOTHYROIDISM Thyroxine reduces epicardial fat tissue mass in subclinical hypothyroidism
Sayin I et al. Thickening of the epicardial adipose tissue can be alleviated by thyroid hormone replacement therapy in patients with subclinical hypothyroidism. Kardiol Pol. April 26, 2016 [Epub ahead of print].
(PDF File for saving and printing, 125 KB)
ATA ALLIANCE FOR THYROID PATIENT EDUCATION
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.